Thus, paroxetine-mediated inhibition of GRK2 enhances cardiac performance, reverses sympathetic overstimulation, normalizes the myocardial βAR functions, and protects the heart after myocardial infarction (MI) (Table 2). The gene discussed is GRK2; the disease is myocardial infarction.